Group Post |
Novavax’s Covid-19 vaccine wins backing of CDC advisory panel |
FNUOvviyaa |
Group Post |
Biden names U.S. monkeypox coordinators as more states cite emergencies |
FNUOvviyaa |
Group Post |
Report dives into Latinos’ trust in science, representation in STEM |
FNUOvviyaa |
Group Post |
New study estimates how many children will get long Covid |
FNUOvviyaa |
Group Post |
COVID cases drop 9% globally last week, deaths stable |
FNUOvviyaa |
Group Post |
WHO: COVID cases, deaths in Africa drop to lowest levels yet |
FNUOvviyaa |
Group Post |
Lack of info on China’s COVID-19 surge stirs global concern |
FNUOvviyaa |
Group Post |
Booster shots needed against omicron, CDC studies show |
FNUOvviyaa |
Group Post |
Funding the search for answers about post COVID-19 condition: how Stichting Long COVID is stimulating research in the Netherlands |
FNUOvviyaa |
Group Post |
Mosquito populations surge in parts of California after tropical storms and triple-digit heat |
FNUOvviyaa |
Group Post |
WHO: COVID cases and deaths falling nearly everywhere |
FNUOvviyaa |
Group Post |
BA.5 spurs new calls to fund next-generation COVID-19 vaccines |
FNUOvviyaa |
Group Post |
U.S. can conduct 60,000-80,000 monkeypox tests per week, HHS secretary says |
FNUOvviyaa |
Group Post |
Monkeypox: Another Lesson in Global Health Neglect |
FNUOvviyaa |
Group Post |
Moderna expects to price its COVID vaccine at about $130 in the US |
FNUOvviyaa |
Group Post |
US hits more than 100M COVID-19 cases. Experts say this is likely an undercount |
FNUOvviyaa |
Group Post |
Patient, Beware: Some States Still Pushing Ineffective Covid Antibody Treatments |
FNUOvviyaa |
Group Post |
Can you get long COVID if you were vaccinated? |
FNUOvviyaa |
Group Post |
Older Americans bore brunt of COVID-19 deaths during the omicron wave |
FNUOvviyaa |
Group Post |
FDA authorizes Novavax Covid vaccine, in hopes the traditional shot will convince holdouts |
FNUOvviyaa |
Group Post |
FDA authorizes Covid-19 vaccines for younger children |
FNUOvviyaa |
Group Post |
Friday Q&A: Matthew Binnicker, Mayo Clinic’s director of clinical virology, talks COVID-19, monkeypox testing |
FNUOvviyaa |
Group Post |
Second Booster Protects Against Breakthrough COVID-19 Variant Infections in Health Care Workers |
FNUOvviyaa |
Group Post |
Masks and flying: Everything you need to know about new US rules |
FNUOvviyaa |
Group Post |
'Natural Immunity' Holds Up Against Severe Omicron Cases in Qatar Study |
FNUOvviyaa |
Recent Comments